Pharmacyte Biotech Inc (PMCB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 04/30
| 10-2020 | 07-2020 | 04-2020 | 01-2020 | 10-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,717 | 2,167 | 895 | 142 | 45 |
| TOTAL | $3,812 | $2,303 | $1,038 | $209 | $209 |
| Non-Current Assets | |||||
| Investments And Advances | 1,572 | 1,572 | 1,572 | 1,572 | 1,572 |
| Intangibles | 3,549 | 3,549 | 3,549 | 3,549 | 3,549 |
| Other Non-Current Assets | 7 | 7 | 7 | 7 | 7 |
| TOTAL | $5,129 | $5,129 | $5,129 | $5,129 | $5,129 |
| Total Assets | $8,941 | $7,432 | $6,167 | $5,338 | $5,338 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 54 | 42 | 29 | N/A | N/A |
| Accounts payable and accrued liabilities | 80 | 385 | 186 | 341 | 165 |
| Accrued Expenses | 509 | 727 | 817 | 678 | 639 |
| TOTAL | $644 | $1,153 | $1,031 | $1,019 | $804 |
| Non-Current Liabilities | |||||
| Long Term Debt | 21 | 34 | 46 | N/A | N/A |
| TOTAL | $21 | $34 | $46 | $N/A | $N/A |
| Total Liabilities | $665 | $1,187 | $1,078 | $1,019 | $804 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,634 | 1,634 | 1,634 | 1,037 | 974 |
| Common Shares | 234 | 188 | 0 | 143 | 133 |
| Retained earnings | -105,692 | -104,742 | -103,858 | -103,108 | -102,233 |
| Other shareholders' equity | -22 | -19 | -22 | -21 | -21 |
| TOTAL | $8,277 | $6,245 | $5,089 | $4,319 | $4,535 |
| Total Liabilities And Equity | $8,941 | $7,432 | $6,167 | $5,338 | $5,338 |